We aim at developing next generation precision medicines for unmet medical needs. Our focus is the engineering of innovative immunomodulatory biologics. Within this endeavor, we have created alphaSEPT. AlphaSEPT is a novel signaling molecule within the human immune system. It is a potential first-in-class pharmaceutical to treat sepsis, an infectious disease with very high mortality rates and no causative treatment options available. Currently, we are looking for a highly motivated protein biochemist to strengthen our newly established team.
The ideal candidate will drive early pre-clinical development of alphaSEPT. He/She will work on the production, biophysical characterization and development of alphaSEPT towards a biopharmaceutical ready for the clinics. The candidate will work in the in-house lab as well as with several academic cooperation partners at other institutions and contract research organizations (CROs).
The position is associated with the laboratory of Cellular Protein Biochemistry (www.cell.ch.tum.de) at the Technical University of Munich (TUM), a leading research university in Europe. The salary is in accordance to the Public Sector Collective Agreement on Länder (TV-L E13/100%). The position is limited to two years. The earliest starting date is October 1st 2020. Only applications received until August 31st 2020 will be considered.
We are looking forward to your application including a CV, (degree) certificates, a letter of motivation and at least two possible references. Please send your application as a single pdf- document by email to: firstname.lastname@example.org.
TUM is an equal opportunity employer. Qualified women are therefore particularly encouraged to apply. Applicants with disabilities are treated with preference given comparable qualification.